D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 74 Citations 18,338 345 World Ranking 12524 National Ranking 179

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Psychiatry

His primary areas of investigation include Immunology, Multiple sclerosis, Myelin oligodendrocyte glycoprotein, Antibody and Pathology. Thomas Berger studied Multiple sclerosis and Autoantibody that intersect with Aquaporin 4. Thomas Berger combines subjects such as Epitope, Encephalomyelitis, Myelin basic protein and Acute disseminated encephalomyelitis with his study of Myelin oligodendrocyte glycoprotein.

His work deals with themes such as Cellular differentiation, Central nervous system and Bioavailability, which intersect with Antibody. His study in Pathology is interdisciplinary in nature, drawing from both Magnetic resonance imaging and Microglia. His Clinically isolated syndrome study combines topics in areas such as Gastroenterology and Internal medicine, Central nervous system disease.

His most cited work include:

  • Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event (546 citations)
  • A synaptic organizing principle for cortical neuronal groups (513 citations)
  • Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. (433 citations)

What are the main themes of his work throughout his whole career to date?

Multiple sclerosis, Randomized controlled trial, Clinical psychology, Immunology and Psychological intervention are his primary areas of study. His Multiple sclerosis research is multidisciplinary, incorporating elements of Myelin and Internal medicine, Disease, Pathology. Thomas Berger works mostly in the field of Randomized controlled trial, limiting it down to topics relating to Physical therapy and, in certain cases, Quality of life, as a part of the same area of interest.

Thomas Berger interconnects Psychotherapist, Social anxiety, Psychiatry and Internet based in the investigation of issues within Clinical psychology. His Immunology study is mostly concerned with Antibody, Myelin oligodendrocyte glycoprotein, Autoantibody, Neuromyelitis optica and Antigen. The Psychological intervention study combines topics in areas such as Mental health and Cognitive behavioral therapy.

He most often published in these fields:

  • Multiple sclerosis (28.36%)
  • Randomized controlled trial (17.72%)
  • Clinical psychology (17.54%)

What were the highlights of his more recent work (between 2018-2021)?

  • Randomized controlled trial (17.72%)
  • Psychological intervention (16.60%)
  • Intervention (12.13%)

In recent papers he was focusing on the following fields of study:

Thomas Berger spends much of his time researching Randomized controlled trial, Psychological intervention, Intervention, Clinical psychology and Depression. His study in Randomized controlled trial focuses on Cognitive behavioral therapy in particular. His study explores the link between Psychological intervention and topics such as Psychosis that cross with problems in Schizophrenia.

His research in Intervention focuses on subjects like Clinical trial, which are connected to Affect and Sample. In the field of Clinical psychology, his study on Distress overlaps with subjects such as Alliance. His Depression research is multidisciplinary, incorporating elements of Psychotherapist, Blended treatment, Meta-analysis and MEDLINE.

Between 2018 and 2021, his most popular works were:

  • Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology: (62 citations)
  • International multicenter examination of MOG antibody assays. (46 citations)
  • Pro-inflammatory activation of microglia in the brain of patients with sepsis. (27 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Psychiatry

His primary scientific interests are in Randomized controlled trial, Psychological intervention, Intervention, Multiple sclerosis and Clinical psychology. His Randomized controlled trial research is multidisciplinary, relying on both Physical therapy, Psychopathology, Depression and Anxiety. In Psychological intervention, Thomas Berger works on issues like Meta-analysis, which are connected to Outcome and Internet based interventions.

The concepts of his Intervention study are interwoven with issues in Medical emergency, Position paper, Disease and Quality of life. His Multiple sclerosis research integrates issues from Disability progression, Retinal and Neuroscience, Olfactory system. His research in Clinical psychology intersects with topics in Patient satisfaction and Mental health.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event

Thomas Berger;Paul Rubner;Franz Schautzer;Robert Egg.
The New England Journal of Medicine (2003)

743 Citations

A synaptic organizing principle for cortical neuronal groups

Rodrigo Perin;Thomas K. Berger;Henry Markram.
Proceedings of the National Academy of Sciences of the United States of America (2011)

608 Citations

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

Monika Bradl;Tatsuro Misu;Toshiyuki Takahashi;Mitsutoshi Watanabe.
Annals of Neurology (2009)

530 Citations

Heterogeneity in the pyramidal network of the medial prefrontal cortex

Yun Wang;Henry Markram;Philip H Goodman;Thomas K Berger.
Nature Neuroscience (2006)

483 Citations

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.

Simone Mader;Viktoria Gredler;Kathrin Schanda;Kevin Rostasy.
Journal of Neuroinflammation (2011)

452 Citations

Antibody to aquaporin-4 in the Long-Term Course of Neuromyelitis Optica

S Jarius;F Aboul-Enein;P Waters;B Kuenz.
Brain (2008)

449 Citations

Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.

Markus Reindl;Chris Linington;Uschi Brehm;Robert Egg.
Brain (1999)

420 Citations

Effectiveness of a Novel Integrative Online Treatment for Depression (Deprexis): Randomized Controlled Trial

Björn Meyer;Thomas Berger;Franz Caspar;Christopher G Beevers.
Journal of Medical Internet Research (2009)

397 Citations

The spectrum of MOG autoantibody-associated demyelinating diseases

Markus Reindl;Franziska Di Pauli;Kevin Rostásy;Thomas Berger.
Nature Reviews Neurology (2013)

370 Citations

Internet-Based Treatment of Depression: A Randomized Controlled Trial Comparing Guided with Unguided Self-Help

Thomas Berger;Katja Hämmerli;Nina Gubser;Gerhard Andersson.
Cognitive Behaviour Therapy (2011)

364 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Thomas Berger

Gerhard Andersson

Gerhard Andersson

Linköping University

Publications: 214

Hans Lassmann

Hans Lassmann

Medical University of Vienna

Publications: 112

David Daniel Ebert

David Daniel Ebert

Technical University of Munich

Publications: 96

Pim Cuijpers

Pim Cuijpers

Vrije Universiteit Amsterdam

Publications: 96

Per Carlbring

Per Carlbring

Stockholm University

Publications: 95

Heleen Riper

Heleen Riper

Vrije Universiteit Amsterdam

Publications: 88

Kazuo Fujihara

Kazuo Fujihara

Fukushima Medical University

Publications: 87

Sven Jarius

Sven Jarius

Heidelberg University

Publications: 80

Friedemann Paul

Friedemann Paul

Max Delbrück Center for Molecular Medicine

Publications: 80

Markus Reindl

Markus Reindl

Innsbruck Medical University

Publications: 75

Brigitte Wildemann

Brigitte Wildemann

University Hospital Heidelberg

Publications: 60

Patrick Waters

Patrick Waters

University of Oxford

Publications: 59

Harald Baumeister

Harald Baumeister

University of Ulm

Publications: 55

Hans-Peter Hartung

Hans-Peter Hartung

Heinrich Heine University Düsseldorf

Publications: 54

Xavier Montalban

Xavier Montalban

Autonomous University of Barcelona

Publications: 53

Cristina Botella

Cristina Botella

Instituto de Salud Carlos III

Publications: 53

Trending Scientists

Sameer Agarwal

Sameer Agarwal

Google (United States)

Paris Avgeriou

Paris Avgeriou

University of Groningen

Shouhua Feng

Shouhua Feng

Jilin University

Ayyakkannu Manivannan

Ayyakkannu Manivannan

West Virginia University

Kang Li

Kang Li

Imperial College London

Edward L. Dreizin

Edward L. Dreizin

New Jersey Institute of Technology

John Christodoulou

John Christodoulou

University of Melbourne

Ian J. Molineux

Ian J. Molineux

The University of Texas at Austin

Michiaki Kubo

Michiaki Kubo

Kyushu University

Anne E. Carpenter

Anne E. Carpenter

Broad Institute

David Danielpour

David Danielpour

Case Western Reserve University

Matthew B. Stern

Matthew B. Stern

University of Pennsylvania

Ichizo Nishino

Ichizo Nishino

Tokyo Medical University

Richard Dodel

Richard Dodel

University of Duisburg-Essen

Slavoj Žižek

Slavoj Žižek

University of Ljubljana

M. L. Perl

M. L. Perl

Stanford University

Something went wrong. Please try again later.